Scientific Program

November 4, 2023 (Saturday)
Room 201, 2F
13:30-16:30 Pre-conference Workshop: Controversies of COVID-19 Vaccines
  Moderator: Bruce Mungall (Singapore), Po-Ren Hsueh (Taiwan)
13:30-14:10 Adenovirus-Vectored COVID-19 Vaccine: Effective and Safe?
13:30-13:50 Adenovirus-Vectored COVID-19 Vaccine: Pros
Bruce Mungall (Singapore)
13:50-14:10 Adenovirus-Vectored COVID-19 Vaccine: Cons
Ping-Ing Lee (Taiwan)
Room 201, 2F
14:10-14:50 mRNA COVID-19 Vaccine: Effective and Safe?
14:10-14:30 mRNA COVID-19 Vaccine: Pros
Andrea Carfi (USA)
14:30-14:50 mRNA COVID-19 Vaccine: Cons
Chih-Jung Chen (Taiwan)
Room 201, 2F
14:50-15:30 Inactivated Whole-Cell COVID-19 Vaccine: Effective and Safe?
14:50-15:10 Inactivated Whole-Cell COVID-19 Vaccine: Pros
Juan Carlos Jaramillo (USA)
15:10-15:30 Inactivated Whole-Cell COVID-19 Vaccine: Cons
Kuan-Ying A. Huang (Taiwan)
Room 201, 2F
14:50-15:10 Protein Subunit COVID-19 Vaccine: Effective and Safe?
15:30-15:50 Protein Subunit COVID-19 Vaccine: Pros
Robert Walker (USA)
15:50-16:10 Protein Subunit COVID-19 Vaccine: Cons
Chien-Chang Lee (Taiwan)
16:10-16:25 Discussion
16:25-16:30 Concluding Remarks
  Po-Ren Hsueh (Taiwan)
Room 201, 2F
16:30-16:50 Opening Ceremony
  Chair: Tzou-Yien Lin (Taiwan)
Room 201, 2F
16:50-17:30 Keynote Speech
  Moderator(s): Li-Min Huang (Taiwan), Tzou-Yien Lin (Taiwan)
Targeting Human Viruses with Low-Sugar Universal Vaccines
Chi-Huey Wong (Taiwan)
17:30-18:10 Keynote Speech
  Moderator(s): Li-Min Huang (Taiwan), Tzou-Yien Lin (Taiwan)
Novel Approaches in Immunization
Bruce Mungall (Singapore)
Banquet Hall, 3F
18:10-21:30 Welcome Reception

November 5, 2023 (Sunday)
Room 201, 2F
08:00-10:00 Plenary Session 1
  Moderator(s): Kim Mulholland (Australia), Ping-Ing Lee (Taiwan)
08:00-08:40 Vaccines for Emerging Infectious Disease: Past, Present, and Future
Kim Mulholland (Australia)
08:40-09:20 A New Malaria Vaccine
Adrian Hill (UK)
09:20-10:00 Influenza Vaccine: A Mystery Inside an Enigma
Ping-Ing Lee (Taiwan)
10:00-10:20 Coffee Break
Room 201, 2F
10:20-12:20 Plenary Session 2
  Moderator: Eun Hwa Choi (Korea), Yhu-Chering Huang (Taiwan)
10:20-11:00 Which COVID-19 vaccine is the best?
Yhu-Chering Huang (Taiwan)
11:00-11:40 Virus-vectored Vaccine and mRNA Vaccine: Unique Immune Responses and Unique Adverse Reactions
Ger T. Rijkers (Netherlands)
11:40-12:20 Time-of-Day Considerations for Vaccinations
Christoph Scheiermann (Switzerland)
Room 201, 2F
12:20-13:40 Lunch symposium 1: The New Era of Prevention for Herpes Zoster (GSK sponsored)
  Moderator: Ping-Ing Lee (Taiwan)
12:20-13:20 The New Era of Prevention for Herpes Zoster
Tino F. Schwarz (Germany)
13:20-13:40 Q&A
Room 102, 1F
12:20-13:40 Lunch symposium 2: The Emerging Trend of HPV Gender Neutral Vaccination (MSD sponsored)
  Moderator: Po-Yen Chen (Taiwan)
12:20-12:30 Opening
12:30-13:10 The Emerging Trend of HPV Gender Neutral Vaccination
Elmar Joura (Austria)
13:10-13:40 QA & Closing
Banquet Hall, 3F
12:20-13:40 Lunch symposium 3: Deep Understanding of mRNA Science and Its Infinite Possibilities (Moderna sponsored)
  Moderator: Yhu-Chering Huang (Taiwan), Nan-Chang Chiu (Taiwan)
12:20-12:25 Opening
12:25-12:50 Interpreting mRNA: Exploring Its Fundamental Characteristics, Safety, and Significant Role in the Future of Medicine
Mi-Hua Tao (Taiwan)
12:50-13:15 The Clinical Journey of mRNA Vaccines: Looking at the Present the Various Possibilities for the Future
Chun-Yi Lu (Taiwan)
13:15-13:35 Q&A & Discussion
Nan-Chang Chiu (Taiwan)
13:35-13:40 Closing
Room 201, 2F
14:00-15:30 Session 2A: COVID-19 Vaccines (1)
  Moderator: Akihiko Saitoh (Japan), Yi-Tsung Lin (Taiwan)
14:00-14:25 The Use of COVID-19 Vaccine in Children
Akihiko Saitoh (Japan)
14:25-14:50 Immunogenicity and Effectiveness of BNT and CoronaVac Vaccines in Hong Kong Children
Yu-lung Lau (Hong Kong)
14:50-15:15 Monitoring of Adverse Events Following COVID-19 Vaccination
Wei-I Huang (Taiwan)
15:15-15:30 15 minutes Discussion
Room 102, 1F
14:00-15:30 Session 2B: Hepatitis, Measles, Mumps and Rubella Vaccines
  Moderator: Nobuhiko Okabe (Japan), Po-Yen Chen (Taiwan)
14:00-14:25 Preventive Strategies Against Hepatitis
Po-Yen Chen (Taiwan)
14:25-14:50 The Use of Hexavalent Vaccine in Infants
Hyunju Lee (Korea)
14:50-15:15 Global Resurgence and Control Strategies of Measles and Rubella
Nobuhiko Okabe (Japan)
15:15-15:30 15 minutes Discussion
15:30-15:50 Coffee Break
Room 201, 2F
15:50-17:20 Session 3A: COVID-19 Vaccines (2)
  Moderator: Ki Wook Yun (Korea), Yee-Chun Chen (Taiwan)
15:50-16:15 Impact of COVID-19 on the Epidemiology of Respiratory Tract Infection: The Immune Debt.
Eun Hwa Choi (Korea)
16:15-16:40 COVID-19 Vaccine Implementation in the Children and Adolescent Population and Risk Communication
Hyunju Lee (Korea)
16:40-17:05 Do We Need Variants COVID-19 Vaccine: The Role of Conserved Neutralizing Epitope and T-Cell Immunity
Robert Walker (USA)
17:05-17:20 15 minutes Discussion
Room 102, 1F
15:50-17:20 Session 3B: Rotavirus and Norovirus Vaccines
  Moderator: Tony Nelson (China), Chun-Yi Lu (Taiwan)
15:50-16:10 Impact of Rotavirus Vaccination on Childhood Gastrointestinal Infection
Yhu-Chering Huang (Taiwan)
16:10-16:30 Correlates of Protection: Using Rotavirus as an Example
Nabi Kanibir (Turkey)
16:30-16:50 Implementing Rotavirus Vaccines in National Immunization Programmes
Tony Nelson (China)
16:50-17:10 Current Development and Challenges of Norovirus Vaccines
Ming Tan (USA)
17:10-17:20 10 minutes Discussion
Room 201, 2F
17:20-18:20 Evening symposium 1 - Are We at Risk? An Update of Neisseria Meningitidis (GSK sponsored)
  Moderator: Yhu-Chering Huang (Taiwan)
17:20-18:00 Are we at risk? An Update of Neisseria Meningitidis
Po-Yen Chen (Taiwan)
18:00-18:20 Q&A
Room 102, 1F
17:20-18:20 Evening symposium 2: Emergence of Serotype 3 and Resurgence of Non-Vaccine-Type: Implications on Invasive Pneumococcal Disease Prevention & ACIP Guidelines Update (MSD Sponsored)
  Moderator: Tzou-Yien Lin (Taiwan)
17:20-17:25 Opening
17:25-18:00 Emergence of Serotype 3 and Resurgence of Non-Vaccine-Type: Implications on Invasive Pneumococcal Disease Prevention & ACIP Guidelines Update
Cheng-Hsun Chiu (Taiwan)
18:00-18:20 QA & Closing
Banquet Hall, 3F
17:20-18:20 Evening symposium 3 - Optimizing Influenza Prevention Strategies: From Standard to Innovative Vaccines (CSL Seqirus sponsored)
  Moderator: Ping-Ing Lee (Taiwan), Chih-Jung Chen (Taiwan)
17:20-17:25 Opening
Ping-Ing Lee (Taiwan)
17:25-17:55 Enhanced influenza vaccines for the 65 y+ population: adjuvant-MF59
Daniel Furtner (Austria)
17:55-18:10 Cost Effectiveness of Cell-based Quadrivalent Influenza Vaccine (QIVc) in Taiwanese Pediatric Population
Chia-Yu Chi (Taiwan)
18:00-18:20 Q&A, closing
Diamond Tony's 101 Panorama Restaurant
18:30-21:30 Presidential Dinner (invited only)

November 6, 2023 (Monday)
Room 201, 2F
08:00-09:30 Session 4A: Human Papillomavirus Vaccine
  Moderator: Daniel Goh (Singapore), Kao-Pin Hwang (Taiwan)
08:00-08:25 Lessons Learned from HPV Vaccination Program in Japan
Akihiko Saitoh (Japan)
08:25-08:50 HPV Vaccination in Singapore: Strategies for a Successful School-Based Programme
Daniel Goh (Singapore)
08:50-09:15 Gender-Neutral Vaccination /Head and Neck Cancer Prevention
Elmar Joura (Austria)
09:15-09:30 15 minutes Discussion
Room 102, 1F
08:00-09:30 Session 4B: Tuberculosis and DTP Combination Vaccine
  Moderator: Zulkifli Ismail (Malaysia), Hsin Chi (Taiwan)
08:00-08:25 Preventive Strategies Against Pertussis
Zulkifli Ismail (Malaysia)
08:25-08:50 Safety and Effectiveness of BCG Vaccine
Nan-Chang Chiu (Taiwan)
08:50-09:15 Development and Challenge of Tuberculosis Vaccine
Ting-Yu Yen (Taiwan)
09:15-09:30 15 minutes Discussion
Room 101
09:30-09:50 Coffee Break
Room 201, 2F
09:50-11:20 Session 5A: Varicella and Herpes Zoster Vaccine
  Moderator: Tino F. Schwarz (Germany), Ren-Bin Tang (Taiwan)
09:50-10:15 Varicella, Herpes Zoster, and Stroke
Boon-Fatt Tan (Taiwan)
10:15-10:40 Effectiveness and Long-Term Protection of Varicella Vaccine in the Real World.
Luan-Yin Chang (Taiwan)
10:40-11:05 Epidemiology of Herpes Zoster and Herpes Zoster Vaccine
Tino F. Schwarz (Germany)
11:05-11:20 15 minutes Discussion
Room 102, 1F
09:50-11:20 Session 5B: Influenza Vaccine
  Moderator: Sajid Maqbool (Pakistan) , Yung-Feng Huang (Taiwan)
09:50-10:10 Influenza, Influenza Vaccine and Cerebrovascular Disease
Hsin Chi (Taiwan)
10:10-10:30 Cell-Based Influenza Vaccine Manufacturing Improves the Probability of Well-Matched Vaccines
Daniel Furtner (Austria)
10:30-10:50 Influenza Vaccines for the Elderly: Protection Beyond the Flu
Angel Chu (Canada)
10:50-11:10 What's New in Influenza Vaccine: Focus on Adjuvanted Influenza Vaccine
Hee-Jin Cheong (Korea)
11:10-11:20 10 minutes Discussion
Room 201, 2F
11:20-12:50 Session 6A: Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium
  Moderator: Iqbal Ahmad Memon (Pakistan), Wen-Sen Lee (Taiwan)
11:20-11:45 Update on the Implementation of PCV in Children in the Asia Pacific Region
Lulu Bravo (Philippines)
11:45-12:10 Changing Epidemiology of Pneumococcal Infection in the Post-Vaccine Era
Cheng-Hsun Chiu (Taiwan)
12:10-12:35 Pneumococcal Conjugate Vaccines: Old Man's Friend
Ger T. Rijkers (Netherlands)
12:35-12:50 15 minutes Discussion
Room 102, 1F
11:20-12:50 Session 6B: Vaccines for Vector-Borne Viral Diseases and Meningococcal Infection
  Moderator: Sanath P. Lamabadusuriya (Sri Lanka); Ching-Chuan Liu (Taiwan)
11:20-11:40 Overview of Japanese Encephalitis Vaccines
Rajeshwar Dayal (India)
11:40-12:00 Development of Dengue Vaccine
Chiam Sue Yin (Malaysia)
12:00-12:20 Meningococcus Vaccine
Po-Yen Chen (Taiwan)
12:20-12:40 One Step Closer to a Single-Dose Chikungunya Vaccine: Update on Valneva’s Live-Attenuated Vaccine Candidate
Gerard Vondeling (Austria)
12:40-12:50 10 minutes Discussion
Room 201, 2F
12:50-13:50 Lunch symposium 4: The New Generations of Pneumococcal Vaccines (Pfizer sponsored)
  Moderator: Feng-Yee Chang (Taiwan)
12:50-12:55 Opening
12:55-13:35 The New Generations of Pneumococcal Vaccines
Cheng-Hsun Chiu (Taiwan)
13:35-13:45 Discussion
13:45-13:50 Closing
Room 102, 1F
12:50-13:50 Lunch symposium 5: New Evidence and Recommendations in Influenza and Pediatric Vaccination (Sanofi sponsored)
  Moderator: Ping-Ing Lee (Taiwan), Yhu-Chering Huang (Taiwan)
12:50–12:55 Opening
12:55–13:20 Influenza Vaccines for Protection Beyond Flu
Alireza Mafi (Turkey)
13:20–13:45 The Value and Recommendation of Hexavalent Vaccination
Chun-Yi Lu (Taiwan)
13:45–13:50 Discussion & Closing
Room 201, 2F
13:50-15:20 Session 7A: Respiratory Syncytial Virus Vaccine
  Moderator: Christian Felter (UK), Chun-Yi Lee (Taiwan)
13:50-14:10 The Burden of RSV in Adults
Grant Waterer (Australia)
14:10-14:30 Respiratory Syncytial Virus Vaccine: Epidemiology and Vaccine Development
Renato T. Stein (Brazil)
14:30-14:50 Respiratory Syncytial Virus Vaccine
Tino F. Schwarz (Germany)
14:50-15:10 Prevention of Respiratory Syncytial Virus in all Infants with Passive Immunization Using Monoclonal Antibodies
Christian Felter (UK)
15:10-15:20 10 minutes Discussion
Room 102, 1F
13:50-15:20 Session 7B: New Vaccine Development
  Moderator: Patrick Woo (Hong Kong), Po-Ren Hsueh (Taiwan)
13:50-14:15 Development of Pseudovirus Nanoparticle-Based Vaccines
Ming Tan (USA)
14:15-14:40 A Candidate Vaccine for Talaromyces Marneffei: Insights for Fungal Vaccine Development
Patrick Woo (Hong Kong)
14:40-15:05 Enterovirus 71 Infections and Vaccine Development
Chun-Yi Lu (Taiwan)
15:05-15:20 15 minutes Discussion
15:30-21:00 Local Tour and Dinner (Self-Pay)